CONTACT INFORMATIONBIOGRAPHYCREDENTIALSAWARDSCLINICAL TRIALSPUBLICATIONSHaoming Qiu, M.D.Contact InformationPhone NumbersAppointment: (585) 275-2171Appointment: (585) 396-6180Office: (585) 275-5625A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsLocationsFF Thompson Hospital Radiation Oncology395 West StPOBCanandaigua, NY 14424-1723Radiation Oncology: (585) 396-6180Wilmot Cancer Institute Radiation Oncology601 Elmwood AveRochester, NY 14642-0001Radiation Oncology: (585) 275-2171Faculty AppointmentsAssistant Professor of Clinical Radiation Oncology - Department of Radiation Oncology (SMD) Patient Care SettingRadiation OncologyBiographyProfessional BackgroundDr. Haoming (Carl) Qiu is a radiation oncologist at the University of Rochester Medical Center seeing patients at both Wilmot Cancer Center in Rochester and Sands Cancer Center in Canandaigua. Dr. Qiu received his medical education at the Johns Hopkins University School of Medicine in Baltimore, MD and completed his residency in radiation oncology at the University of Rochester Medical Center. Dr. Qiu brings a high level of technical expertise along with a friendly and optimistic attitude in caring for his patients. Dr. Qiu also provides Lutathera (lutetium Lu 177 dotatate) PRRT (Peptide Receptor Radionuclide Therapy) for patients with neuroendocrine tumors. If you are interested in a consultation, please have your doctor call our office for a referral. (585) 275-5625.ResearchDr. Qiu's research is focused on the use of radiation therapy in the treatment of gastrointestinal and lung cancers with a special focus on the use of stereotactic body radiotherapy (SBRT) to deliver ablative doses of radiation with high levels of precision and conformality.. Dr. Qiu also directs the palliative radiation service at URMC, providing treatments aimed at alleviating symptoms for patients with advanced cancers Dr. Qiu is the author of several peer reviewed articles and has presented his research at numerous national and international meetings in oncology.CredentialsSpecialtiesRadiation Oncology - American Board of RadiologyEducation2011MD | Johns Hopkins HospitalPost-doctoral Training & Residency07/01/2013 - 06/30/2016Residency in Radiation Oncology at University of Rochester Medical Center07/02/2012 - 06/30/2013Residency in Radiation Oncology at Loyola University Medical Center06/23/2011 - 06/22/2012Internship in Internal Medicine at Sinai Hospital of BaltimoreVIEW ALL expand_moreAwards2015Roentgen Resident/Fellow Research AwardSponsor: RSNA Research and Education FoundationLocation: University of Rochester Medical Center2011Excellence in Medical Student ResearchLocation: Johns Hopkins University School of MedicineClinical TrialsA Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction AdenocarcinomaLead Researcher: Haoming Qiu This phase II/III trial studies the usefulness of treatment with nivolumab and ipilimumab in addition to standard of care chemotherapy and radiation therapy in patients with esophageal and gastroesophageal junction adenocarcinoma who are undergoing surgery. Immunotherapy with antibodies, such as nivolumab and ipilimumab, may remove the brake on the body's immune system and may interfere with the ability of tumor cells to grow and spread. Chemotherapy and radiation therapy may reduce the tumor size and the amount of normal tissue that needs to be removed during surgery. A combined treatment with nivolumab and ipilimumab, chemotherapy, and radiation therapy might be more effective in patients with esophageal and gastroesophageal junction adenocarcinoma who are undergoing surgery. View Study Details A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)Lead Researcher: Haoming Qiu This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy with radiation therapy may kill more tumor cells. This study may help doctors find out if lower-dose chemoradiation is as effective and has fewer side effects than standard-dose chemoradiation, which is the usual approach for treatment of this cancer type. View Study Details PublicationsJournal Articles2022Mills BN; Qiu H; Drage MG; Chen C; Mathew JS; Garrett-Larsen J; Ye J; Uccello TP; Murphy JD; Belt BA; Lord EM; Katz AW; Linehan DC; Gerber SA. "Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy". Clin Cancer Res. 2022; 28(1): 150-162.2/2021Komisarof J, Qiu H, Velez MJ, Mulford D. "Anterior mediastinal large cell neuroendocrine carcinoma with elevated AFP: A case report and review." Molecular and clinical oncology.. 2021 Feb 0; 14(2):34. Epub 2020 Dec 22. 2021Battaglia NG; Uccello TP; Hughson A; Garrett-Larsen J; Caldon JJ; Qiu H; Gerber SA; Lord EM. "Co-administration of a clinically relevant dexamethasone dosage with ablative radiotherapy reduces peripheral lymphocytes but does not alter in vivo intratumoral lymphocyte phenotype or inhibit efficacy of radiotherapy in a murine colorectal tumor model." International journal of radiation oncology, biology, physics. 2021; 111(1): 284-296.Books & Chapters2021 Chapter Title: Oligometastatic Disease – Basic Aspects and Clinical Results Book Title: Medical Radiology: Radiation Oncology: Advances in Radiation Oncology in Lung Cancer Author List: Sakthivel G, Singh DP, Qiu H, Milano MT Edited By: Jeremic B Published By: Springer 20212021 Chapter Title: Programed Death Receptor-1 (PD-1) Book Title: Medical Radiology: Radiation Oncology: Advances in Radiation Oncology in Lung Cancer Author List: Qiu H, Chen Y Edited By: Jeremic B Published By: Springer 2021 in New YorkVIEW ALL PUBLICATIONSClose WindowSchedule an appointment with Haoming Qiu, M.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Haoming Qiu, M.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.